Ascendis Pharma Income from Continuous Operations 2015-2024 | ASND
Ascendis Pharma income from continuous operations for the twelve months ending June 30, 2024 was $-0.530B, a 17.05% decline year-over-year.
- Ascendis Pharma annual income from continuous operations for 2023 was $-0.521B, a 15.2% decline from 2022.
- Ascendis Pharma annual income from continuous operations for 2022 was $-0.614B, a 35.4% increase from 2021.
- Ascendis Pharma annual income from continuous operations for 2021 was $-0.454B, a 5.17% decline from 2020.